A drug that targets multiple pathogenic steps in diabetic retinopathy may be an ideal therapeutic strategy for the disease, Vanderbilt researchers report.

Paul Sternberg Jr., MD, recently received the American Academy of Ophthalmology EnergEYES Award, given by the academy’s young ophthalmologists.

The Vanderbilt Eye Institute (VEI) has received a $10 million gift that will fund regenerative visual neuroscience research to develop transformative therapies for eye diseases.

Vanderbilt Eye Institute researchers have discovered that an imbalance in the ionic environment of retinal ganglion cells may contribute to functional impairments in glaucoma.

Vanderbilt Eye Institute receives grants to Research to study causes, treatment and prevention of blinding diseases.

Cataracts are uncommon in babies but when they occur the cloudy lenses must be removed without delay or blindness may result.

When Josh Robinson, OD, chose to specialize in low vision optometry, he was certain of one thing — his services would have a big impact on his patient population — and it is proving to be true.